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HIV prevention in prisons
Do international guidelines matter?
PAOLA BOLLINI, JEAN-DOMINIQUE LAPORTE, TIMOTHY W. HARDING *
Background: In spite of the availability of international guidelines, HIV prevention and management of care in prison
is still unsatisfactory in many countries. Factors affecting the quality of HIV prevention policies in prison have not
yet been elucidated. The present study had two aims: i) to assess national HIV prevention policies in prison in a
selected group of countries; and ii) to determine which factors influenced such policies at the country level. Methods:
HIV prevention policies in prison were reviewed comparatively in Moldova, Hungary, Nizhnii Novgorod region of the
Russian Federation, Switzerland and Italy. The review of HIV prevention policies in prison was conducted through
interviews with government officials, non-governmental organizations, professionals involved in this field, and visits
to selected prisons. Information on the health of prisoners, including tuberculosis, sexually transmitted diseases,
and other infectious diseases has also been collected. Results: The results indicated that all countries had adopted
a policy, irrespective of the burden of HIV infection in the prison system. The content of the policy mirrored the
philosophy and strategies of HIV prevention and care in the community. The 1993 WHO Guidelines were fully
implemented only in one country out of four (Switzerland), and partially in two (Italy and Hungary). Conclusions: A
greater effort aimed at dissemination of information, provision of technical know-how and material resources could
be the answer to at least part of the problems identified. In addition, greater national and international efforts are
needed to stimulate the debate and build consensus on harm reduction activities in prison.
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Prisons are increasingly emerging as a critical area for HIV
prevention, due to the high concentration of persons with
behaviours at risk for HIV transmission and the scarcity
of prevention means.1 Studies conducted in several
countries have shown that imprisonment remained
significantly associated with HIV infection among in-
jecting drug users (IDUs) after adjustment for other risk
factors.2–4 Furthermore, HIV transmission in prison has
been documented in a number of countries.5
The World Health Organization (WHO) has issued
technical recommendations for the management and pre-
vention of HIV infection in prisons on two separate
occasions, 1987 and 1993.6,7 The 1993 WHO Guidelines
emphasize voluntary testing, confidentiality, non-
discrimination of HIV-positive inmates, availability of
prevention means, and access to treatment equivalent to
that in the community. However, several surveys have
pointed out that HIV prevention and management of care
in many penitentiary systems are still far from satis-
factory.1,3,8–10 Factors that hamper the implementation
of the 1993 WHO Guidelines in penitentiary institutions
have been the object of little systematic evaluation so far.
In particular, it is not clear whether the content of the
1993 WHO Guidelines is inappropriate or too ambitious
for prison settings, or whether insufficient efforts were
made to disseminate and implement them. To answer
these questions, a comparative study of HIV prevention
policies in the penitentiary system of five Eastern and
Western European countries has been conducted, with
two main objectives:
to assess the current situation of HIV prevention in
prison in a selected group of countries; and
to determine which factors influenced the national
policies of HIV prevention and care in the prison system.
The results of this study will hopefully assist governments,
National AIDS Programmes, and prison administrations
in the evaluation of present policy choices and in the
development of appropriate responses.
METHODS
Four countries have been selected for this study, two in
Eastern and two in Western Europe: Moldova, Hungary,
Italy, and Switzerland. In addition, the region of Nizhnii
Novgorod, a large administrative region of the Russian
Federation has also been included. It will be considered
as the fifth country throughout the report, its HIV
prevention policy in prison being that of the Russian
Federation. The five countries differ considerably in
terms of traditions, organization and resources of the
penitentiary system, prevalence of HIV infection in
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prisons, and implementation of prevention activities.
These differences, however, are key to highlight the
complexities of HIV prevention in Eastern and Western
European prisons.
Traditional methods of policy analysis, which include
both qualitative and quantitative approaches, have been
employed. The review of HIV prevention policies in the
penitentiary system has been conducted during visits to
each country, from May 1997 to February 1999. Informa-
tion has been sought from government officials, non-
governmental organizations concerned with HIV/AIDS
and prisoners’ human rights, and professionals involved
in this field, as well as through interviews with UNAIDS
officials and members of the Committee for the Pre-
vention of Torture of the Council of Europe. A list of
institutions contacted in each country is given in
Appendix 1. Interviews were conducted in English,
Italian, and French. In Moldova, Nizhnii Novgorod and
Hungary the presence of an interpreter has been necessary
during most interviews. For each country quantitative
data on the year of onset of the HIV/AIDS epidemic, the
cumulative number of AIDS cases (or number of reported
HIV infections), and the percentage of HIV/AIDS cases
accounted for by drug use were extracted from national
statistics. In addition, the rate of prisoners per 100,000
population and the estimated percentage of HIV-infected
prisoners was reported.
The analysis of the country policy’s objectives and imple-
mentation, and the identification of the most important
policy players have been conducted following the general
framework provided by Reich.11 Policy analysis has been
complemented by collection of available information on
the health of prisoners, in particular HIV/AIDS, tuber-
culosis, sexually transmitted diseases (STDs), and other
infectious diseases routinely collected through the prison
health information system. Early in the study it became
clear that it was impossible to understand HIV prevention
policies in prison outside the context of the national HIV
prevention policy for society at large. Accordingly, the
latter has also been reviewed in each country, with special
attention to HIV prevention among injection drug users
(IDUs).
Finally, it was possible to visit prisons in Moldova, Nizhnii
Novgorord, Hungary, and Switzerland, while permission
was not granted in Italy. A detailed review of each country
results is available upon request.
RESULTS
Summary information on the HIV/AIDS epidemic in
each country is shown in table 1. The five countries
studied differed in terms of HIV/AIDS prevalence in the
community, onset of the epidemic and main mode of
transmission. Switzerland and Italy had the highest
cumulative incidence of AIDS cases in Europe, long
established drug markets, and a substantial percentage of
AIDS cases accounted for by drug use. In contrast,
Moldova and Nizhnii Novgorod experienced a recent
HIV/AIDS epidemic, intravenous drug use being the
main mode of transmission. Finally, Hungary had a
very low cumulative incidence of AIDS cases, and only
one case accounted for by drug use, the main mode
of transmission being represented by men having sex
with men.
At the time of the visits the Ministry of Justice was
responsible for the prison system in four of the countries
considered, while in Switzerland the various cantons were
in charge of prisons (table 2). The five countries differed
in the rate of incarcerated population, and prison over-
crowding was serious in Italy, and very dramatic in
Moldova and Nizhnii Novgorod Region, especially in the
pre-trial detention centres. The most relevant health
problems identified by prison health authorities were
strictly dependent on the living standards in prisons, and
on the composition of the prison population. Malnutrition,
tuberculosis, and STDs were very serious in Moldova and
Nizhnii Novgorod region.19,20 Infectious diseases control
was not a problem in Swiss prisons, where a high pre-
valence of mental health problems and heavy smoking
had been revealed by a national survey of institutionalized
populations.21 In Hungary mental health problems were
considered important by prison doctors, while the control
of infectious diseases did not pose any problem. Little
epidemiological information on the prevalence of
infectious diseases and other conditions was available in
Italy. However, several independent observers indicated
the health consequences of overcrowding as the major
health problem in Italian prisons, followed by the high
prevalence of HIV infection among prisoners.
Table 1 Summary data on the HIV/AIDS epidemic
Total 
population
Year of onset of the
HIV/AIDS epidemic
Cumulative number of AIDS
cases (or number of reported
HIV infections)
Percentage of HIV/AIDS
cases accounted for by
drug use
Moldova 4,490,000 1987 97a 81
Hungary 10,246,000 1985 265b 0.4
Nizhnii Novgorod Region 3,500,000 1996 652c ∼ 80
Switzerland 6,995,000 1982 4,995d 35
Italy 57,193,000 1982 ∼ 37,000e 58
a: Number of HIV infected, as of 25 March 1997.12 
b: Cumulative number of AIDS cases as of 30 September 1997.13 
c: Number of HIV infections reported, as of 17 February 1999.14 
d: Cumulative number of AIDS cases as of 31 December 1995.15 
e: Cumulative number of AIDS cases as of 31 December 1996.16 
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Health care in prison was differently organized in the five
countries, but nowhere was it part of the national health
care delivery scheme. In Moldova, Hungary and Nizhnii
Novgorod Region medical services were a specific unit
within the prison administration department and prison
physicians were employed by the prison administration.
In Italy approximately 4,000 contract physicians, both
specialists and general practitioners, provided health care
to prisoners. Contract physicians were not part of the
administrative structure of the MOJ, and they did not
hold positions of responsibility within the prison ad-
ministration. Finally, in Switzerland the different cantons
had their own arrangements, often under the respons-
ibility of the Director of Justice and Police.
The impact of HIV in the prison systems was largely
influenced not only by the prevalence of IDUs in society
and by the degree of HIV infection among IDUs, but also
by the sentencing policies adopted by each country for
drug-related crimes. Sentencing policy was strict in Italy
and Nizhnii Novgorod Region, leading to a high number
of incarcerated drug addicts. The number of drug addicts
in prison was still limited in Moldova and Hungary, due
to the recent onset of drug addiction in the former and to
the adoption of a policy of alternative punishment (de-
toxification in the community) in the latter country.
Switzerland fell between the two extremes, with about
one-third of prisoners convicted for drug-related crimes.22
The prevalence of HIV-infected prisoners is shown in
table 2. With the exception of Switzerland, information
on prevalence of risk factors in prison was anecdotal, for
two main reasons. First, the penitentiary administrations
lacked the necessary epidemiological skills and/or the
resources to implement specific studies, and second some
issues such as sexual violence and availability of illicit
drugs within prisons were considered quite sensitive, and
it was preferred to ignore them.
Overall, in the five countries considered the prison health
administration dealt with any health problem using its
own skills and resources, sometimes admittedly inad-
equate, without collaborating with other sectors of the
public administration or receiving attention from non-
governmental sectors. HIV/AIDS, however, represented
the exception. The recognition of the problems linked to
HIV prevention and management in prisons followed
different paths in the countries studied. However, the
local associations against HIV/AIDS played a key role in
identifying the problem, soliciting solutions, and pro-
viding external support and advocacy throughout. Both
the voluntary sector (better developed for historical
reasons in Switzerland and Italy, and less in Hungary,
Nizhnii Novgorod Region and Moldova) and the
National AIDS Programmes considered HIV/AIDS as a
global problem, investing all sectors of society. Prisoners
became a legitimate target of advocacy and support. The
activity of the associations had different emphasis in the
five countries. In Italy the Italian League against AIDS
(LILA) focused its attention on legislative changes aimed
at early discharge of prisoners with AIDS, according to
the principle of incompatibility between AIDS and
prison. In Switzerland the National AIDS Commission
suggested investigating the situation in Swiss prisons
already in 1986, and continued monitoring the situation
thereafter. In Hungary the National AIDS Programme
started an early collaboration with the Prison Service,
providing information material and medical supervision
to HIV positive prisoners. In Moldova the United
Nations Theme Group, the local association of inter-
national organizations against AIDS, funded the first
seminar on HIV prevention in prisons. Finally, in Nizhnii
Novgorod the local Association for Human Rights
received letters from inmates with HIV/AIDS com-
plaining about their situation, and decided to contact an
international NGO for technical support.
HIV prevention in prison, and in particular harm re-
duction strategies, mirrored harm reduction strategies in
society, which were in turn affected by the prevalent
attitude towards drug addiction and its cure. Only
Switzerland had implemented a wide spectrum of harm
reduction activities in the community, ranging from ex-
change of syringes to prescription of heroin under medical
supervision. These activities were a well-established pillar
of the federal policy to fight drug addiction, and enjoyed
large public opinion support as a necessary medical treat-
ment to persons affected by a severe disease. In contrast,
in Italy harm reduction activities were still debated and
not widely implemented, in spite of the large proportion
of HIV infection accounted for by intravenous drug use.
In Hungary, the authorities in charge of drug addiction
Table 2 Institutional responsibility for penitentiary institutions, rate of inmates per 100,000 population, and number of HIV-positive prisoners
Institutional responsibility
Rate of prisoners per
100,000 population
Percentage of HIV-
infected prisoners
Moldova Department of Penitentiary Systems, Ministry of Justice 219 per 100,000 ∼ 0.1a
Hungary Hungarian Prison Service, Ministry of Justice 124 per 100,000 0.03b
Nizhnii Novgorod Region Regional Administration of Penal Institutions, Ministry 
of Justice 800 per 100,000 0.8c
Switzerland Department of Justice and Police, Cantonal authorities 81 per 100,000 4–12d
Italy Department of Penitentiary Institutions, Ministry of Justice 83 per 100,000 ∼ 7e
a: Testing was limited to a few prisons.
b: Based on testing of all new admissions.
c: Based on testing of all new admissions.
d: Based on voluntary testing in selected prisons.17 
e: Based on voluntary testing of about one third of new admissions.18 
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were still developing a national policy, but they were not
in favour of harm reduction programmes. Only one needle
exchange programme, implemented by a local NGO with
international funding, was functioning in Budapest by the
end of 1997. In Nizhnii Novgorod Region the federal
legislation strongly discouraged any harm reduction pro-
gramme. Finally, Moldova did not have any treatment or
harm reduction programme at the time of the study, but
a syringe exchange pilot project was considered.23
In our sample, Switzerland was the only country that
adopted an active policy of HIV prevention and care in
prison, including harm reduction activities, based on the
principle of equivalence of prevention and care between
prison and the community (table 3). In Italy HIV policy
in prisons focused on information, provision of care to
HIV/AIDS cases, and early discharge of the terminally ill,
while harm reduction activities, and in particular bleach,
syringe exchange and condoms, were not implemented
nor under consideration. In Moldova the prison adminis-
tration intended to start a rather active programme of
information and possibly some harm reduction activities
in the prison system, fearing the extension of the
HIV/AIDS problem to an unmanageable level, as in
neighbouring Romania and Ukraine, countries with
which Moldova had frequent exchanges. In Hungary,
information was provided to all prisoners, but no harm
reduction programme was implemented. HIV screening
and isolation of positive cases was implemented to protect
HIV-negative prisoners from the risk of becoming in-
fected through sexual intercourse. In Nizhnii Novgorod
Region the official policy in prison focused on mandatory
screening and isolation of HIV-positive prisoners to
protect other prisoners and staff.
The main aspects of policy implementation in the countries
considered are summarized in table 4, according to the
main items of the 1993 WHO Guidelines. Voluntary
testing was applied in Switzerland and Italy, but in the
latter confidentiality of test results was not assured.
Testing was mandatory and results not confidential in
Hungary and in Nizhnii Novgorod Region, while
mandatory screening was started in Moldova and then
stopped for lack of funds. Treatment of HIV/AIDS cases
was equivalent to that available in the community in four
out of five countries, ranging from no treatment in
Moldova, to treatment with AZT in Nizhnii Novgorod
Region, to treatment with triple therapy in both Hungary
and Switzerland. In Italy treatment with triple therapy
was considered experimental in the community, and it
was not yet available in prison. Concerning HIV pre-
vention, information was provided in three out of five
countries, while harm reduction activities (provision of
condoms, disinfectant or syringes) were seldom im-
plemented. In Moldova, Nizhnii Novgorod and Italy con-
doms were not made available. Harm reduction activities
for IDUs, including syringe exchange and methadone
maintenance, were implemented only in Switzerland out
of the five countries considered.
DISCUSSION
The first goal of the study was to assess the current policies
of HIV prevention and care in the prison systems of a
selected group of countries. The countries studied are not
homogeneous, and any further comparison has to take
into account the differences in the prison traditions of
Table 3 HIV/AIDS prevention in prisons: main policy objectives
Moldova
To provide information to all prisoners
To implement limited harm reduction activities
Hungary
To provide information to all prisoners
To protect HIV-negative prisoners from HIV transmission
Nizhnii Novgorod Region
To protect HIV-negative prisoners and prison staff from
HIV transmission
Switzerland
To provide information to all prisoners
To ensure equivalence of prevention and care between
prison and the community, including provision of harm
reduction activities
Italy
To provide information to all prisoners
To provide treatment to HIV-positive/AIDS prisoners
equivalent to that in the community
Table 4 HIV prevention and management in prison
Moldova Hungary
Nizhnii Novgorod
Region Switzerland Italy
Management of care
Voluntary testing no noa no yes yes
Confidentiality of test results no no no yes no
Segregation of HIV-positive prisoners yes yes yes no no
Provision of equivalent treatment yes yes yes yes no
Prevention/harm reduction
Provision of information no yes no yes yes
Condom availability no yesb no yesc no
Bleach, syringes, methadone maintenance,
opiates substitution no no no yesc no
a: Test is mandatory, but consent is asked.
b: Before home leave.
c: Limited to some prisons.
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Eastern and Western Europe. The prison systems in
Hungary, and especially in Moldova and Nizhnii
Novgorod, are in transition from a totalitarian and op-
pressive labour camp style of incarceration to one based
on the values of the Council of Europe. The adoption of
internationally accepted policies on the treatment of
prisoners with HIV/AIDS is part of that process, which
encompasses the assumption of new responsibilities for
the health of prisoners in front of society.
The results indicated that all countries had adopted a
policy (or were in the process of defining it), irrespective
of the burden of HIV infection present in the prison
system. Additional resources were allocated to prevent
and control HIV infection even in Moldova, where very
few HIV cases were registered, other diseases were pre-
valent, and resources were extremely limited. One aspect
common to all countries was the co-operation between
the prison health services and outside health agencies,
which is a unique case in the panorama of health in
prison, an area traditionally separated from community
public health.8 Two reasons may possibly explain such
collaboration. First, the national and international
mobilization created around AIDS, including the social
and scientific discourse centred around human rights
issues, had given legitimacy and visibility to the problem
of HIV/AIDS in prisons. The associations and the
National AIDS Programmes considered prisoners as
vulnerable groups in need of specific attention, and
solicited action from the prison administrations. Second,
the latter were quite unprepared to deal with the
challenges posed by prevention and care of HIV/AIDS in
prisons, especially where co-morbidity with tuberculosis
posed a serious hazard, and solicited co-operation and
exchange. Such co-operation was not always smooth in
all countries, but it was certainly innovative. It is worth
noting that the ‘external’ attention to HIV in prisons has
also created at the international level an unprecedented
awareness of other health and safety problems of
prisoners, including tuberculosis, mental health and
violence. International initiatives and studies currently
ongoing are focusing on mental health and hepatitis
besides HIV/AIDS (WHO Health in Prison Network, the
European Network on HIV/AIDS Prevention in Prisons
and the European Network of Drugs and HIV/AIDS
Services in Prisons).
The content of the policy mirrored in the five countries
the philosophy and strategies of HIV prevention and care
in the community, with delays due to the separation
which existed between prison and society, and to the
prevailingly custodial role of the prison system.24 For
example, voluntary testing and lack of segregation in
Italian and Swiss prisons followed the directions and
policies of the National AIDS programmes. In contrast,
in Eastern European countries the epidemic was much
more recent, and the national response to HIV/AIDS still
followed the traditional approach to the control of in-
fectious diseases requiring case identification, isolation
and tracing of contacts. In all countries provision of
information was part of the policy (or intended to be such
in the case of Moldova and Nizhnii Novgorod Region,
where the authorities had scarce resources available).
Actually, the period spent in detention was seen by prison
authorities as a good opportunity to convey a neutral
message on what should and should not be done once
freedom was regained. Provision of care was also equi-
valent to that available in the community, with obvious
differences among countries, and with the only exception
of Italy, where delays in the availability of the most
updated therapies were registered. Finally, harm reduction
strategies in prison followed the mainstream societal values
on treatment of drug addiction, either preservation of life
(through avoidance of infection), long-term abstinence
(through a personal effort to get rid of any form of addiction),
or simply repression of drug use. Switzerland in the sample
was the only country with well-developed harm reduction
strategies for drug addicts in the community, which was
extended to prisons as well. Overall, the 1993 WHO
Guidelines were fully implemented only in one country
out of five, and partially in two (Italy and Hungary). A
legitimate question was whether the 1993 WHO Guide-
lines were not followed because they were inadequate to
prison settings, or whether other factors hampered their
implementation at the country level.
The 1993 WHO Guidelines were written to provide
indication to prison administrators on the most appro-
priate way to manage the care of HIV-infected in prison,
and prevent new infections. Their main thrust was that
public health concerns – preservation of individual life,
limitation of epidemic spread – should override com-
peting social considerations and institutional priorities
even in prison settings. Furthermore, equivalence of care
between prisons and the society needed to be assured. The
1993 WHO Guidelines were based on factual evidence
(HIV is not transmitted through casual contact, bleach
kills the virus), and on widely accepted procedures
(voluntary testing, pre-post test counselling, etc.). One
may disagree with such premises, but it is difficult to
imagine different guidelines in the context of the current
international discourse on the HIV epidemic. Further-
more, the 1993 WHO Guidelines were fully implemented
in Switzerland, and partially in other countries, without
major unintended consequences, pointing out that
their implementation was feasible in different realities.
But what factors hampered the implementation at the
country level?
The main justification brought forward for partial im-
plementation was the presence of legislation and prison
rules that prohibited specific actions. However, the prison
health staff were also ready to point out ‘pragmatic’ ways
to overcome the current obstacles, or to suggest amend-
ments to the current legislation. But other factors were at
work in the countries considered. First, in Moldova and
Nizhnii Novgorod Region the prison authorities were not
aware that such guidelines existed, and did not have them
available in the national language. Second, certain aspects
were not relevant in some countries, as in Hungary where
the number of IDUs imprisoned was negligible due to an
alternative sentencing policy, and the provision of bleach
HIV prevention in prisons
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or syringes was therefore not envisaged by the prison
authorities. Third, in some cases prison authorities did not
have adequate knowledge of monitoring techniques such
as anonymous unlinked surveys of prevalence and risk factors
for HIV infection, and therefore mass screening remained
the only solution available. Fourth, as in the case of Moldova
and Nizhnii Novgorod, the prison administration had the
will but not the resources to implement information or
condom distribution programmes. And fifth, even when
resources were available some issues remained contro-
versial and politically sensitive, in particular syringe ex-
change, methadone, and condom distribution.
Usually, prisoners are not a group attracting sympathy
from the public. In many societies it is felt that prisoners
deserve punishment, and that they should have access to
a minimal set of services. The provision of condoms or
bleach may be seen as condoning sex and drug use in
prisons, thus breaking the delicate balance between
punishment and care. As a class, prisoners do not have
influential friends, and the only way they can get attention
is by violent or demonstrative actions.24 In Moldova
many public officials pointed out that it was difficult to
propose activities benefiting prisoners. In Italy, NGOs
active in the domain of prisoners’ rights highlighted the
scarce interest of the media and the Italian public in issues
relating to prisons. Only in Switzerland was the attitude
rather more positive, because of the declared rehabilita-
tion goal of the penitentiary system. In none of the
countries studied have prisoners or their families lobbied
to have access to HIV prevention means. The League of
Mothers of Prisoners of Nizhnii Novgorod, the only or-
ganized group of prisoners’ relatives that the authors met,
was actively lobbying to have better living conditions for
HIV-positive prisoners. In Italy, HIV-positive prisoners
performed demonstrative actions to attract attention to
their condition in the early 1990s, and a hunger strike in
October 1997 to protest against the difficult living con-
ditions and inadequate care of drug addicts and
HIV/AIDS cases.25,26 It has to be noted that it was diffi-
cult for prisoners and their families to make direct requests
for harm reduction, especially in prison systems which
offered rewards pending good behaviour – sex and inject-
ing drugs usually not considered as such in prison.
This study highlighted the complexities behind HIV pre-
vention and management in prisons. Amending the 1993
WHO Guidelines would not ensure a step forward.
Instead, a greater effort aimed at dissemination of in-
formation, provision of technical know-how and material
resources could be the answer to at least part of the above
problems, after a careful review of the needs of each
country. The situation is particularly urgent in Eastern
European countries, which are now facing the first wave
of HIV infection in prisons, due to a delayed onset of
intravenous drug use and HIV infection in the society
compared to the rest of Europe.27 But many countries in
Western Europe and in the United States still do not
implement harm reduction programmes, as indicated by
the case of Italy in this study and by the results of recent
surveys.1,3,9 This finding highlights the fact that the
solutions to the current problems are not only of technical
nature. Implementing HIV prevention in prison touches
sensitive aspects of each country’s internal policy, and in
some cases it accompanies a process of democratization
and opening to outside scrutiny of the prison system. It is
therefore necessary to implement joint efforts, both
nationally and internationally, in order to stimulate the
debate and to build consensus on the most controversial
issues.
National AIDS Programmes should regularly review HIV
prevention and management in prison, and advocate
changes when needed on the basis of the principle of
equivalence between prison and the community. Inter-
national organizations active in this domain should in-
crease their current efforts, fostering discussion and parti-
cipation through country visits, policy reviews, regular
monitoring of 1993 WHO Guidelines implementation,
and international studies. Concerning the latter, it is
important to stress that in the only country in this study
where the 1993 WHO Guidelines were fully implemented
– Switzerland – harm reduction activities were first intro-
duced as pilot projects, duly evaluated, and then imple-
mented on a larger scale.28 There is no reason why such
a strategy could not be replicated elsewhere, not only to
influence national policies, but also to provide evidence
at the international level on the best ways to implement
prevention and harm reduction activities in prison.
The study was partially supported by the Institute of Legal Medicine,
University of Geneva, by Penal Reform International, London, and
by UNAIDS, Geneva. 
We wish to thank Sandro Libianchi, Massimo Pavarini, Joachim
Nelles, Denes Banhegyi, David Koch, Peter Gerber, and an un-
known reviewer for their invaluable comments on the manuscript. 
Parts of the paper were presented at the Joint WHO/UNAIDS
European Seminar on HIV/AIDS, sexually transmitted diseases and
tuberculosis in prisons. Warsaw, 14–16 December 1997.
  REFERENCES  
1 Braithwaite RL, Hammet T, Mayberry RM. Prisons and AIDS: 
a Public Health Challenge. S. Francisco: Jossey-Bass Publishers, 1996.
2 Rotily M, Galinier-Pujol A, Obadia Y, et al. HIV testing, HIV 
infection and associated risk factors among inmates in
South-Eastern French prisons. AIDS 1994;8(9):1341-4.
3 Weilandt C, Rotily M. European Network on HIV/AIDS 
Prevention in Prisons. 1996 Report. Marseille: Observatoire Regional
de la Santé Provence, Alpes, Côte d’Azur, and Bonn: WIAD,
Scientific Institute of the German Medical Association, 1997.
4 UNAIDS. Relationships of HIV and STD declines in Thailand 
to behavioural change: a synthesis of existing studies. Geneva:
UNAIDS Best Practice Collection, 1998.
5 Jürgens R. VIH/SIDA et prisons: rapport final (HIV/AIDS and 
prisons: final report). Réseau juridique canadien VIH/SIDA. Société
canadienne du sida. Montréal, Septembre 1996.
6 WHO Special Programme on AIDS. Statement from the 
Consultation on Prevention and Control of AIDS in Prisons.
Geneva: 16-18 November 1987; WHO/SPA/INF/87.14.
7 WHO Global Programme on AIDS. WHO Guidelines on HIV 
Infection and AIDS in prisons. Geneva: March 1993.
WHO/GPA/DIR/93.3.
8 Harding TW. Do prisons need special health policies and 
programmes? In: Nelles J, Fuhrer A, editors. Harm reduction in
prisons. Bern: Peter Lang, 1997:161-80.
9 Laporte JD. Results of a survey in European prisons: 
HIV/AIDS, sexually transmitted diseases and tuberculosis in
EUROPEAN JOURNAL OF PUBLIC HEALTH VOL. 12  2002  NO. 2
88
prisons. Proceedings of the Joint WHO/UNAIDS European
Seminar; 1997 Dec 14-16; Popowa, Poland. Copenhagen: World
Health Organization, Regional Office for Europe.
10 Perkins S. Access to condoms in prisons of the European 
Union. London: project report, 1998. Brussels: European Union.
11 Reich MR. The politics of health sector reform in 
developing countries: three cases of pharmaceutical policy.
Health Policy 1995;32:47-77.
12 Georghitsa S. Personal communication. National AIDS 
Centre; Chisinau, 1997.
13 Johan Bela National Institute of Hygiene. HIV positive 
persons detected in Hungary by 30 September 1997. Budapest:
Johan Bela National Institute of Hygiene, 1997.
14 Volga AIDS Centre Surveillance System. Cumulative 
number of HIV infections in the Volga region. Nizhnii Novgorod:
Volga AIDS Centre, Technical report, 1999.
15 Dubois-Arber F, Jeannin A, Meystre-Augustoni G, 
Moreau-Gruet F, Haour-Knipe M, Spencer B, Paccaud F.
Evaluation of the AIDS prevention strategy in Switzerland
mandated by the Federal Office of Public Health. Lausanne:
Institut Universitaire de Médecine Sociale et Preventive; 1997
Fifth Assessment report IUMPS/UEPP.
16 Centro Operativo AIDS. Sindrome da Immunodeficienza 
Acquisita (AIDS) in Italia: aggiornamento dei casi notificati al 31
Marzo 1997 (AIDS in Italy: updated statistics at 31 March 1997).
Roma: Istituto Superiore di Sanità, 1997.
17 Nelles J, Dobler-Mikola A, Kaufmann B. Provision of 
syringes and prescription of heroin in prison: the Swiss experience
in the prisons of Hindelbank and Oberschöngrün. In: Nelles J,
Fuhrer A, editors. Harm reduction in prisons. Bern: Peter Lang,
1997:239-62.
18 Dipartimento Amministrazione Penitenziaria. Indagine 
Nazionale sui Soggetti Tossicodipendenti e Affetti dal Virus HIV
negli Istituti Penitenziari: rilevamento al 31/12/96 (National
inquiry on drug addicts and HIV infected persons in penitentiary
institutions on 31 December 1996). Roma: Ministero di Grazia e
Giustizia, 1997.
19 Leorda A. Report on the prison system of Moldova. 
Typescript. Paper presented at the first national workshop on
prophylaxis of HIV/AIDS and of injecting drug use among the
prisoners in the penitentiary institutions; 1997 May 15-16;
Chisinau (Moldova): Ministry of Justice, 1997.
20 Bollini P. Visit to penitentiary institutions of Nizhnii 
Novgorod region, and workshop on HIV prevention in prison for
local prison officials and NGOs. London: Penal Reform
International; 1999; Mission Report.
21 Koller C. La consommation de drogues dans les prisons 
suisses (Illicit drugs consumption in Swiss prisons). In: Nelles J,
Fuhrer A, editors. Harm reduction in prisons. Bern: Peter Lang,
1997:83-114.
22 Office Fédéral de la Statistique (OFS). Drogues et droit 
pénal en Suisse: séries chronologiques des dénonciations,
jugements pénaux et exécutions de peines, 1974-1994 (Illicit
drugs and penal code in Switzerland: chronological statistics of
denunciations, trials and sentence implementation). Bern: Office
Fédéral de la Statistique, 1995.
23 Cerbotarenco N. Syringe exchange implementation 
program in Moldova. Typescript. Chisinau: Association Drugs;
1999 First Report.
24 Prout C, Ross RN. Care and Punishment: the dilemmas of 
prison medicine. Pittsburgh: University of Pittsburgh Press, 1988.
25 Stocco A. Detenuti, si allarga la protesta (Detainees: the 
protest grows). Il Messaggero 1997 Oct 24.
26 Bisso M. Rebibbia, volontariato in campo: i detenuti non 
protestano da soli (Rebibbia, non-governmental organization join
the protest: prisoners are not alone). La Repubblica 1997 Oct 22.
27 Hamers FF, Downs AM, Infuso A, Brunet J-B. Diversity of 
the HIV/AIDS epidemic in Europe. AIDS 1998;12(Suppl.A):63-70.
28 Nelles J, Fuhrer A, Hirsbrunner HP, Harding TW. Provision 
of syringes: the cutting edge of harm reduction in prison? BMJ
1998;317:270-3.
Received 12 November 1999, accepted 3 January 2001
Moldova
Ministry of Health
National AIDS Centre
Medical Service, Department of Penitentiary Systems,
Ministry of Justice
Republican Hospital of Large Profile of the Department 
of Penitentiary Institutions
4th Colony, Cricova Village
Association ‘Drugs’
Theme Group against HIV/AIDS
Hungary
Department of Immunology and Tropical Medicine, 
St. Lázló Hospital, Budapest
Department of Epidemiology, National Institute of Hygiene
Planning Directorate, Hungarian Prison Service, Budapest
Health Department, Hungarian Prison Service, Budapest
Ministry of Welfare, Budapest
Inter-ministerial Drug Committee, Budapest
Hungarian Blood Transfusion Centre, Budapest
Nizhnii Novgorod Region
Regional Administration of Penal Institutions
Sanitary and Epidemiological Surveillance Centre of the
Ministry of Interior
Regional AIDS Centre
Multi-regional AIDS Centre, Volga Region
Nizhnii Novgorod Society for Human Rights
League of Mothers of Prisoners
NGO Support Centre
Nonames Foundation, Moscow
Future without AIDS
Foundation anti-AIDS
Regional Pre-trial Detention Centre
Fifth Colony for male detainees
Second Colony for women detainees
Switzerland
Psychiatric Services of the University of Bern,
Ostermundigen
Institute of Forensic Medicine, Faculty of Medicine, Geneva
Federal Office of Public Health, Bern
Federal Office of Statistics, Bern
UNAIDS, Geneva
Comité Européen pour la Prévention de la Torture, 
Genève
Hindelbank prison, Hindelbank
Italy
Commissione Nazionale AIDS, Roma
Dipartimento Amministrazione Penitenziaria, Roma
LILA, Lazio
ARCI, Roma
CEIS, Roma
Servizio Tossicodipendenti, Carcere Rebibbia, Roma
Associazione Antigone, Roma
Facolta’ di Legge, Universita’ di Bologna
Centro Operativo AIDS, Istituto Superiore Sanita’, Roma
Ministero degli Affari Sociali, Roma
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